antalarmin has been researched along with dactinomycin in 1 studies
| Studies (antalarmin) | Trials (antalarmin) | Recent Studies (post-2010) (antalarmin) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
|---|---|---|---|---|---|
| 181 | 0 | 76 | 19,045 | 355 | 969 |
| Protein | Taxonomy | antalarmin (IC50) | dactinomycin (IC50) |
|---|---|---|---|
| RAD51 | Homo sapiens (human) | 32.1 | |
| Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
| Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, X; Jin, L; Li, C; Li, R; Li, S; Sun, Z | 1 |
1 other study(ies) available for antalarmin and dactinomycin
| Article | Year |
|---|---|
Corticotropin-releasing hormone receptors mediate apoptosis via cytosolic calcium-dependent phospholipase A₂ and migration in prostate cancer cell RM-1.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Movement; Corticotropin-Releasing Hormone; Dactinomycin; Down-Regulation; HEK293 Cells; Humans; Interleukin-1beta; Male; Mice; Mitomycin; Peptide Fragments; Phospholipases A2; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Pyrroles; Receptors, Corticotropin-Releasing Hormone; RNA Interference; RNA, Messenger; RNA, Small Interfering; Thapsigargin; Tumor Necrosis Factor-alpha; Up-Regulation; Urocortins | 2014 |